Title of article :
Clinical application of plasma derived medicines: current situation and future trend
Author/Authors :
Strengers, Paul F. W. Sanquin Blood Supply, Netherlands
From page :
159
To page :
169
Abstract :
Blood plasma consists of a number of functional groups which have a major function in order to maintain or restore the physiological status of the human body. About 13% of the body weight consists of blood including the cellular components erythrocytes, leucocytes and platelets, and plasma. Plasma contains many different substances such as secreted proteins e.g. albumin, clotting factors, fibrinogen, and immunoglobulins (IgG, IgA, IgM, IgD, IgE); tissue leakage products e.g. cardiac myoglobin; “distant” receptor ligands e.g. insulin; “local” receptor ligands e.g. interleukin 8; aberrant secretions e.g. prostate specific antigen (PSA) in prostate cancer; temporary passengers e.g. lysomal enzymes; and foreign proteins e.g. virus. In general, the medicinal products that are isolated from plasma are divided into a number of functional groups: albumin solutions, clotting factor concentrates, immunoglobulins, serine protease inhibitors, and other products.
Journal title :
Iranian Journal of Blood and Cancer (IJBC)
Journal title :
Iranian Journal of Blood and Cancer (IJBC)
Record number :
2669146
Link To Document :
بازگشت